Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis
Authors:
- Manal GabrilMGManal Gabril
- Vladimir V. IakovlevVIVladimir V. Iakovlev
- Andreas ScorilasASAndreas Scorilas
- Youssef M. YoussefYYYoussef M. Youssef
- Hala FaragallaHFHala Faragalla
- Kalman KovacsKKKalman Kovacs
- Fabio RotondoFRFabio Rotondo
- Shereen MetiasSMShereen Metias
- Androu ArsaniousAAAndrou Arsanious
- Anna PlotkinAPAnna Plotkin
- Andrew H.F. GirgisAGAndrew H.F. Girgis
- 1 July 2012
- journal article
- Published by Elsevier in Human Pathology
- Vol. 43 (7) , 1037-1043
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapyBreast Cancer Research and Treatment, 2008
- Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for TherapyClinical Cancer Research, 2008
- CD105 expression is an independent predictor of survival in patients with endometrial cancerGynecologic Oncology, 2006
- Organ‐specific endoglin (CD105) expression in the angiogenesis of human cancersPathology International, 2006
- Endoglin (CD105) expression in human renal cell carcinomaBJU International, 2006
- PROGNOSTIC ROLE OF FUHRMAN GRADE AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN pT1a CLEAR CELL CARCINOMA IN PARTIAL NEPHRECTOMY SPECIMENSJournal of Urology, 2005
- Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancerThe Prostate, 2002
- Elevated expression of endoglin, a component of the TGF-?-receptor complex, correlates with proliferation of tumor endothelial cellsInternational Journal of Cancer, 1999
- Tumor angiogenesis as a prognostic factor in ovarian carcinomaCancer, 1997
- Prognostic significance of morphologic parameters in renal cell carcinomaAmerican Journal of Surgical Pathology, 1982